Herpes simplex virus type 1 (HSV-1) is a neurotrophic human pathogen t
hat naturally persists in neurons in a latent state and carries a larg
e number of viral functions which can be replaced by foreign genes to
create a vector for gene therapy applications. in this report we descr
ibe a two-step method for insertion/deletion mutagenesis of HSV genes
and the efficient insertion of transgenes into these locations in the
viral genome. The first step is the insertion of a reporter gene (lacZ
) cassette flanked by Pacl restriction enzyme sites not otherwise foun
d in the viral genome, using standard marker transfer procedures to in
terrupt a portion of the target HSV gene. The second step is substitut
ion of the reporter gene with other foreign cDNAs by digestion of the
vector DNA with Pacl to remove the lacZ gene and subsequent repair of
the vector genome by homologous recombination with a transgene express
ion plasmid. Potential recombinants indentified by a 'clear plaque' ph
enotype after X-gal staining arose at high frequency (80-100%). Of the
se, recombinants containing the transgene in place of the lacZ gene ra
nged from 19-65%, Insertion of the transgene expression construct into
the viral genome eliminates the Pacl sites allowing this method to be
used repeatedly for the sequential deletion of multiple HSV genes whi
le inserting multiple transgenes. This procedure was repeated in succe
ssion to produce a vector carrying two independent expression cassette
s at distinct viral loci.